← Browse by Condition
Medical Condition

recurrent squamous cell carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT05323253
Recruiting

A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

Enrollment
86 pts
Location
United States, Canad...
Sponsor
Alpha Tau Medical LTD.
View Trial →